According to the research report titled ‘Venous Thromboembolism Treatment Market Size By Device (Compression System, Thrombectomy Systems, IVC Filters, Stockings), By Application (Deep Vein Thrombosis, Pulmonary Embolism), By End-use (Hospitals, Catheterization Laboratories), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 - 2027’, available with Market Study Report, global venous thromboembolism treatment market is touted to grow at an appreciable rate over 2021-2027.
 

Rising prevalence of pulmonary embolism, cancer and obesity, along with escalating number of orthopedic surgeries majorly due to expanding geriatric population are adding considerable momentum to global venous thromboembolism market expansion. Besides, increasing accessibility to advanced catheterization labs, surging demand for better medication for affected patients in line with growing availability of mechanical therapy products are enhancing the industry outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3793266/
 

On the contrary, low awareness regarding venous thromboembolism and post-procedure complications associated with stent placement are negatively impacting the industry outlook.
 

For the uninitiated, venous thromboembolism refers to blood clotting in veins. It is an underdiagnosed condition, which if left without adequate treatment, could cause death or disability. In fact, this health complication is third known vascular ailment after stroke and heart attack that affects nearly 300,000 to 600,000 individuals in America every year.
 

Based on device, global venous thromboembolism treatment industry size from stockings segment is expected to increase at 7.8% CAGR through 2027. The product demand can be ascribed to better patient outcomes like reduced swelling and pain, as well as improved blood flow.
 

In terms of application, the market is split into pulmonary embolism and deep vein thrombosis, among which, the latter segment held over USD 530 million in 2020 and is projected to grow considerably in the upcoming years.
 

With respect to end-use scope, catheterization laboratories segment is set to grow at 9.7% CAGR over the assessment period, attributable to high patient volumes in these establishments and surging demand for better medication.
 

Considering the geographical outlook, North America venous thromboembolism treatment industry is anticipated to generate strong returns in the upcoming years, with U.S. at the forefront. The U.S. sub-market accounted for over 380 million in 2020 and will continue showcasing strong growth trends through 2027, largely due to strong presence of major players, prompt adoption of advanced products, and growing availability of sophisticated cath labs in the country.
 

Prominent players in this domain are Argon Medical Devices Inc., Cook Medical Inc., Daesung Maref Co. Ltd., Coviden (acquired by Medtronic plc), Cardinal Health Inc., AngioDynamics Inc., and Boston Scientific Corp.